These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
464 related articles for article (PubMed ID: 18513254)
1. Evaluation of the Roche cobas s 201 system and cobas TaqScreen multiplex test for blood screening: a European multicenter study. Jarvis L; Becker J; Tender A; Cleland A; Queiros L; Aquiar A; Azevedo J; Aprili G; Bressan F; Torres P; Nieto S; Ursitti A; Montoro J; Vila E; Ramada C; Saldanha J Transfusion; 2008 Sep; 48(9):1853-61. PubMed ID: 18513254 [TBL] [Abstract][Full Text] [Related]
2. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus. Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856 [TBL] [Abstract][Full Text] [Related]
3. Analytical and clinical performance evaluation of the cobas TaqScreen MPX Test for use on the cobas s 201 system. Ohhashi Y; Pai A; Halait H; Ziermann R J Virol Methods; 2010 May; 165(2):246-53. PubMed ID: 20152864 [TBL] [Abstract][Full Text] [Related]
4. HIV-1, HCV and HBV seronegative window reduction by the new Roche cobas TaqScreen MPX test in seroconverting donors. Wiedmann M; Kluwick S; Walter M; Fauchald G; Howe J; Bronold M; Zauke M J Clin Virol; 2007 Aug; 39(4):282-7. PubMed ID: 17611148 [TBL] [Abstract][Full Text] [Related]
5. Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations. Koppelman MH; Assal A; Chudy M; Torres P; de Villaescusa RG; Reesink HW; Lelie PN; Cuypers HT Transfusion; 2005 Aug; 45(8):1258-66. PubMed ID: 16078910 [TBL] [Abstract][Full Text] [Related]
6. Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA. Margaritis AR; Brown SM; Seed CR; Kiely P; D'Agostino B; Keller AJ Transfusion; 2007 Oct; 47(10):1783-93. PubMed ID: 17880602 [TBL] [Abstract][Full Text] [Related]
7. Blood donor screening with cobas s 201/cobas TaqScreen MPX under routine conditions at German Red Cross institutes. Schmidt M; Pichl L; Jork C; Hourfar MK; Schottstedt V; Wagner FF; Seifried E; Müller TH; Bux J; Saldanha J Vox Sang; 2010 Jan; 98(1):37-46. PubMed ID: 19682348 [TBL] [Abstract][Full Text] [Related]
8. One-year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations. Phikulsod S; Oota S; Tirawatnapong T; Sakuldamrongpanich T; Chalermchan W; Louisirirotchanakul S; Tanprasert S; Chongkolwatana V; Kitpoka P; Phanuphak P; Wasi C; Nuchprayoon C; Transfusion; 2009 Jun; 49(6):1126-35. PubMed ID: 19392770 [TBL] [Abstract][Full Text] [Related]
9. Routine screening of blood donations at Qingdao central blood bank, China, for hepatitis B virus (HBV) DNA with a real-time, multiplex nucleic acid test for HBV, hepatitis C virus, and human immunodeficiency virus Types 1 and 2. Yang Z; Xu L; Liu L; Feng Q; Zhang L; Ma W; Saldanha J; Wang M; Zhao L Transfusion; 2013 Oct; 53(10 Pt 2):2538-44. PubMed ID: 23480568 [TBL] [Abstract][Full Text] [Related]
10. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load. Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the analytical and operational performance of two viral nucleic acid test blood screening systems: Procleix Tigris and cobas s 201. Assal A; Barlet V; Deschaseaux M; Dupont I; Gallian P; Guitton C; Morel P; David B; De Micco P Transfusion; 2009 Feb; 49(2):289-300. PubMed ID: 19000230 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of COBAS AmpliPrep nucleic acid extraction in conjunction with COBAS AmpliScreen HBV DNA, HCV RNA and HIV-1 RNA amplification and detection. Koppelman MH; Sjerps MC; Reesink HW; Cuypers HT Vox Sang; 2005 Nov; 89(4):193-200. PubMed ID: 16262751 [TBL] [Abstract][Full Text] [Related]
13. Effect of viral nucleic acid testing on contamination frequency of manufacturing plasma pools. Nübling CM; Unkelbach U; Chudy M; Seitz R Transfusion; 2008 May; 48(5):822-6. PubMed ID: 18208414 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA. McCormick MK; Dockter J; Linnen JM; Kolk D; Wu Y; Giachetti C J Clin Virol; 2006 Jul; 36(3):166-76. PubMed ID: 16427802 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of two, commercial, multi-dye, nucleic acid amplification technology tests, for HBV/HCV/HIV-1/HIV-2 and B19V/HAV, for screening blood and plasma for further manufacture. Müller MM; Fraile MI; Hourfar MK; Peris LB; Sireis W; Rubin MG; López EM; Rodriguez GT; Seifried E; Saldanha J; Schmidt M Vox Sang; 2013 Jan; 104(1):19-29. PubMed ID: 23252689 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand. Nantachit N; Thaikruea L; Thongsawat S; Leetrakool N; Fongsatikul L; Sompan P; Fong YL; Nichols D; Ziermann R; Ness P; Nelson KE Transfusion; 2007 Oct; 47(10):1803-8. PubMed ID: 17880604 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test. Kleinman SH; Strong DM; Tegtmeier GG; Holland PV; Gorlin JB; Cousins C; Chiacchierini RP; Pietrelli LA Transfusion; 2005 Aug; 45(8):1247-57. PubMed ID: 16078909 [TBL] [Abstract][Full Text] [Related]
18. Nucleic acid amplification technology screening for hepatitis C virus and human immunodeficiency virus for blood donations. Bamaga MS; Bokhari FF; Aboud AM; Al-Malki M; Alenzi FQ Saudi Med J; 2006 Jun; 27(6):781-7. PubMed ID: 16758035 [TBL] [Abstract][Full Text] [Related]
19. The efficacy of individual-donation and minipool testing to detect low-level hepatitis B virus DNA in Taiwan. Yang MH; Li L; Hung YS; Hung CS; Allain JP; Lin KS; Tsai SJ Transfusion; 2010 Jan; 50(1):65-74. PubMed ID: 19709394 [TBL] [Abstract][Full Text] [Related]
20. Automated multiplex assay system for simultaneous detection of hepatitis B virus DNA, hepatitis C virus RNA, and human immunodeficiency virus type 1 RNA. Meng Q; Wong C; Rangachari A; Tamatsukuri S; Sasaki M; Fiss E; Cheng L; Ramankutty T; Clarke D; Yawata H; Sakakura Y; Hirose T; Impraim C J Clin Microbiol; 2001 Aug; 39(8):2937-45. PubMed ID: 11474017 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]